| Patient’s Group |
No. of Patients |
Ala67Thr |
References |
| Post-Polio syndrome |
110 |
50 (45.46%) |
Present study |
| Paralytic poliomyelitis |
6 |
1(16.7%) |
[23] |
| Amyotrophic lateral sclerosis (ALS) |
110 |
13 (11.8%) |
[22] |
| Vaccine Associated Paralytic Poliomyelitis (VAPP) |
9 |
1 (11.1%) |
[23] |
| Progressive muscular atrophy (PMA) |
30 |
6 (20%) |
[22] |
| Controls |
200 |
10 (5%) |
Present study |
| Controls |
280 |
19 (6.8%) |
[22] |
| Controls |
56 |
4 (7.1%) |
[20] |
| Controls |
493 |
37 (7.5%) |
[21] |
| Total of all controls |
1029 |
70 (6.8%) |
|
|
